Is Viagra Vulnerable?
Is Viagra Vulnerable?
Eli Lilly’s Cialis lasts for 36 hours–and a $100 million ad blitz will spread the word
It's Wake-Up Time
It’s Wake-Up Time
Kiss your pillow good-bye. A new breed of drugs promises to do for drowsiness what Prozac did for depression.
Biotech plans: Boon or fantasy?
Biotech plans: Boon or fantasy?
Having mapped hormones, synthesized molecules and discovered new cell receptors, the Scripps Research Institute wants to embark on one of its biggest cloning experiments: converting the Sunshine State into biotech beach by using $510 million from taxpayers.
REDISCOVERING NATURAL PRODUCTS
REDISCOVERING NATURAL PRODUCTS
Cast aside for years, natural products drug discovery appears to be reclaiming attention and on the verge of a comeback
Biotech funding on track to bounce back
Biotech funding on track to bounce back
It’s not over yet, but 2003 already looks like a banner year for biotechnology funding in the United States, according to a survey released yesterday by the accounting firm Ernst & Young.
Get updates by email
Editor
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
and Share
Reading
Translator
© Copyright - BiotechBlog — A thinkBiotech product
Recent Comments